Showing results (821-830 of 1,193) with videos related to

Sort By:
Pageof 120
Pharmaceutical Statistics|December 2, 2025
Adaptive Constrained Weighted Estimation for Incorporating Multiple External Information SourcesKeita Takahashi, Kazufumi Okada, Shiro Tanaka, et al.
Pharmaceutical Statistics|November 12, 2025
Great Wall: A Generalized Dose Optimization Design for Drug Combination Trials Maximizing Survival BenefitYan Han, Yingjie Qiu, Yi Zhao, et al.
Pharmaceutical Statistics|June 25, 2025
Estimating the Variance of Covariate-Adjusted Estimators of Average Treatment Effects in Clinical Trials With Binary EndpointsDominic Magirr, Craig Wang, Alexander Przybylski, et al.
Pharmaceutical Statistics|October 14, 2025
Nonparametric Inference for the Covariate-Adjusted Youden Index and Associated Cut-Off Points for Three Ordinal Diagnostic GroupsAsieh Maghami-Mehr, Hamzeh Torabi, Hossein Nadeb, et al.
Pharmaceutical Statistics|July 25, 2025
Sample Size for Enriched Biomarker Designs With Measurement Error for Time-to-Event OutcomesSiyuan Guo, Susan Halabi, Aiyi Liu
Pharmaceutical Statistics|October 25, 2025
Improving Maximum Tolerated Dose Selection in Model-Assisted Designs for Phase I Trials Through Bayesian Dose-Response ModelRentaro Wakayama, Tomotaka Momozaki, Shuji Ando
Pharmaceutical Statistics|October 17, 2025
BOIN-MEM: A Two-Stage Design for Dose Optimization With Information Borrowing Across Dose Levels and Stages in Oncology Phase I/II TrialsRyo Kitabayashi, Kentaro Takeda, Hiroyuki Sato, et al.
Pharmaceutical Statistics|October 9, 2025
Designing and Evaluating Bayesian Advanced Adaptive Randomised Clinical Trials: A Practical GuideAnders Granholm, Aksel Karl Georg Jensen, Theis Lange, et al.
Pharmaceutical Statistics|August 14, 2025
Drift Parameter Based Sample Size Determination in Multi-Stage Bayesian Randomized Clinical TrialsYueyang Han, Haolun Shi, Jiguo Cao, et al.
Pageof 120